Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice
Narjes Nasiri‐Ansari(National and Kapodistrian University of Athens), Eva Kassi(National and Kapodistrian University of Athens)
Cited by 161
Related Papers
Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
|International Journal of Molecular Sciences|2021|288
Estrogen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Atherosclerotic Plaque Vulnerability
|International Journal of Molecular Sciences|2022|14